Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Total Current Liabilities (2023)

Sagimet Biosciences has reported Total Current Liabilities over the past 1 years, most recently at $5.7 million for Q4 2023.

  • Quarterly results put Total Current Liabilities at $5.7 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $5.7 million (changed N/A YoY), and the annual figure for FY2023 was $5.7 million, changed.
  • Total Current Liabilities for Q4 2023 was $5.7 million at Sagimet Biosciences, up from $5.0 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for SGMT hit a ceiling of $5.7 million in Q4 2023 and a floor of $5.0 million in Q3 2023.